Monelar, Anjel Ryz .

HRN: 22-73-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2023
CEFUROXIME 750MG (VIAL)
08/30/2023
09/06/2023
IV
750mg
TID
Acute Gastritis Wt Mod. DHN
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamIntra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: